Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1995;2(2):105–110. doi: 10.1155/MBD.1995.105

Structural Characterization of the Rhenium(V) Oxo Complex of Mercaptoacetyltriglyclne in its Dianionic Form

Lory Hansen 1,, Andrew Taylor Jr 1, Luigi G Marzilli 2
PMCID: PMC2364954  PMID: 18472752

Abstract

Dianionic [MO(MAG3)]2−(MAG3 = penta-anionic form of mercaptoacetyltriglycine, M = 186Re, 99mTc) complexes have important applications in nuclear medicine. In vivo the complexes have a deprotonated carboxyl group that is important to their biodistribution. The solid-state structures of 99Tc and Re complexes with mercaptoacetyltriglycine reported previously are monoanions with protonated carboxyl groups. In the present work, we report the preparation and X-ray crystal structure of Na2[ReO(MAG3)]·5H2O (1), which contains the physiologically relevant dianion. The dianion is a distorted square pyramid with the nitrogen and sulphur donor atoms forming the base and the oxo ligand at the apex. The terminal carboxyl group is deprotonated, uncoordinated and has a syn orientation with respect to the oxo ligand. The syn conformation of the dianion in 1 differs in conformation from the anti-monoanion in [Bu4N][ReO(MAG3H)] but is similar to the syn-monoanion in [Ph4P][99TcO(MAG3 H)].

Full Text

The Full Text of this article is available as a PDF (771.6 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES